about
Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditionsIncreased teicoplanin doses are associated with improved serum levels but not drug toxicity.Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studiesValidation of a Dutch risk score predicting poor outcome in adults with bacterial meningitis in Vietnam and Malawi.Genomic pneumococcal load and CSF cytokines are not related to outcome in Malawian adults with meningitis.High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from MalawiPersistence of pneumolysin in the cerebrospinal fluid of patients with pneumococcal meningitis is associated with mortalityBacterial meningitis in a high HIV prevalence setting in sub-Saharan Africa--challenges to a better outcome.Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trialAdjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.The diagnosis and management of acute bacterial meningitis in resource-poor settings.Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival.Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial.Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.Sensitivity and specificity of an index for the diagnosis of TB meningitis in patients in an urban teaching hospital in Malawi.High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.Infection and low back pain: seeking evidence or fear of exploring new indications for antibiotics?Serial measurement of the C-reactive protein is a poor predictor of treatment outcome in prosthetic joint infection.Grey nails predict low CD4 cell count among untreated patients with HIV infection in Malawi.Prioritizing echocardiography in Staphylococcus aureus bacteraemia.Varicella zoster virus-associated neurological disease in HIV-infected patients.Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTCorrigendum to ‘Staphylococcus aureus bloodstream infection: A pooled analysis of five prospective, observational studies’ [J Infect 68 (2014) 242–251]Over-diagnosis of Clostridium difficileEffect of posture on body temperature of young men in cold airReducing Implant Infection in Orthopaedics (RIIiO): a pilot study for a randomised controlled trial comparing the influence of forced air versus resistive fabric warming technologies on postoperative infection rates following orthopaedic implant surgLymphocytic interstitial pneumonitis in an HIV-infected adult: response to antiretroviral therapyOral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCTCost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial
P50
Q28365296-A4E6C66A-FBD3-4DA4-8A3B-BEE9CBF3F434Q33410202-01F5C6AF-EC79-4F3E-9479-BFF1230C40BCQ34060175-EE57810C-E22B-4587-B2BD-D2F2B4097BD4Q34217886-EE61C635-3F90-4C76-B871-AA9422094256Q34406177-B1E4C5CE-C8B8-4FC2-A41D-CFAF2CA2AEDAQ34874445-8A603282-6430-4E70-934F-42A4448F6966Q35745699-B7CBB4E2-635F-4467-8170-17E87229B7F6Q35931013-7EC8C2CD-C6AE-4B6E-887D-0CB48AED7298Q36393355-DF116FC9-DF7A-4E55-890A-E348915B5C8AQ36568337-45E00866-8C6D-4925-B570-2C4565CE46C4Q37195390-D4B97A20-7365-4CA6-B387-56687E3984E9Q37248844-321EEA44-6DE3-4CAD-AB99-82E4AE8ECEA6Q37347385-FC263C40-146E-46FD-AB66-56E74A8CF15BQ37723052-CF2FC2B4-B5E8-456D-9DBE-72606BC6F03DQ39005541-85AFA357-C22C-449E-BE53-3C013325162CQ39853505-E3437CE6-8579-4C3F-BCE4-0C1BF48A385DQ40441550-28D64B96-23E0-4DB5-81FD-2ABE3233D10AQ43445075-AFE5BE87-5808-4A0C-A7ED-5EA2FC46B129Q43713040-4515A55D-B78C-49FD-8F8D-E842AD8CD316Q43715536-3709040A-510D-48D8-8A2F-2671E6B4BE35Q44964554-48F69BB8-3837-41F4-AA44-31BBFE6CBB18Q45738354-C5C0BD2D-F18C-4FFA-B2C4-34BC19DC2C51Q58124833-04006B8F-A9B5-4832-AD53-FB3D3A6233E1Q59317492-50009A06-B672-4B5F-BC1F-E5B481F7F266Q59317495-0CC51962-8528-4EC6-B855-32B34B669409Q59317501-F4609FB3-ED7D-402C-B35E-785AD8F019CBQ59336678-582FD744-FBD5-47A2-9839-C418F17D39F0Q73457164-AF0B8E88-FB58-405B-BE17-5A9312A8DE4FQ92362585-96E00AF3-2DDA-4AA6-9C2C-824AD4434DC0Q92594752-4A517698-BEEB-4B79-A038-23E651286ADE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Matthew Scarborough
@ast
Matthew Scarborough
@en
Matthew Scarborough
@es
Matthew Scarborough
@nl
Matthew Scarborough
@sl
type
label
Matthew Scarborough
@ast
Matthew Scarborough
@en
Matthew Scarborough
@es
Matthew Scarborough
@nl
Matthew Scarborough
@sl
prefLabel
Matthew Scarborough
@ast
Matthew Scarborough
@en
Matthew Scarborough
@es
Matthew Scarborough
@nl
Matthew Scarborough
@sl
P106
P21
P31
P496
0000-0002-0455-0785